Insights On CONTRACT PHARMA MANUFACTURING
-
Biomanufacturing Operator Training And Solutions
5/20/2025
Discover a hands-on biomanufacturing training program that empowers operators with essential skills, boosts efficiency, and supports innovation in the fast-paced biopharma industry.
-
The Next-Gen Cell Line Development Platform Fueling Biologics Success
5/19/2025
Whether you're navigating the challenges of complex biologics or seeking a faster path to the clinic, this discussion sheds light on how innovation in CLD can be a game-changer for your pipeline.
-
Bend Successfully Rescues Powder-Filled Capsule Program
5/16/2025
Learn how to overcome tech transfer challenges and ensure consistent content uniformity by leveraging multidisciplinary expertise and decades of commercial encapsulation experience.
-
Working With An End-To-End CDMO To De-Risk AAV Production
5/15/2025
Consider how the following strategies can be used to optimize AAV manufacturing by reducing risk and balancing productivity, quality, and cost to meet the growing demands of gene therapy.
-
Unlocking Flexible AAV Production With In-House Plasmids, Manufacturing Capacity
5/15/2025
Discover how 3PBIOVIAN’s advanced plasmid manufacturing and AAVion® platform can drive your AAV program forward by reducing production costs while maximizing efficiency.
-
Utilizing A Stepwise Approach For Nitrosamine Risk Mitigation
5/15/2025
The following insights and case studies demonstrate how a tailored, stepwise testing approach can effectively detect, quantify, and control nitrosamine impurities while maintaining cost efficiency.
-
Adapting A rcAAV Assay For Commercial Manufacturing
5/15/2025
Witness how to implement sensitive, cell-based qPCR assays to reliably detect rcAAVs and safeguard the integrity of your rAAV gene therapy manufacturing process.
-
Simulated Bed Chromatography Advantages
5/15/2025
Discover how Simulated Moving Bed (SMB) technology can revolutionize your purification processes by enhancing efficiency, reducing costs, and promoting sustainable practices.
-
The Seamless Path To Market: End-To-End CDMOs As Your Strategic Ally Douglas CDMO
5/14/2025
Partner with an experienced end-to-end CDMO to streamline development, reduce risk, and accelerate your drug’s path to market in today’s complex and competitive pharmaceutical landscape.
-
Right-Sized For Success: The Benefits Of A Boutique CDMO
5/14/2025
Partner with a right-sized CDMO to gain the agility, expertise, and personalized focus needed to accelerate your drug development with confidence.